ECMO is a selectively available therapeutic option, generally at a large-size referral healthcare system. In a single-center experience of use of veno-venous ECMO for COVID-19 ARDS in a medium-size healthcare system during the pandemic, West and colleagues in their study have convincingly demonstrated that ECMO can become a broadly available therapeutic option without compromising quality.

Extracorporeal membrane oxygenation (ECMO) is a selectively available therapeutic option, generally available in a large‐size referral healthcare system. In a single‐center experience of the use of venovenous ECMO for COVID‐19 ARDS in a medium‐size healthcare system during the pandemic, West et al. in their study have convincingly demonstrated that ECMO can become a broadly available therapeutic option without compromising quality.

This is a commentary on a single-institution retrospective review that describes the short-term outcomes of the pediatric patients who underwent re-operative surgery for residual or recurrent coarctation after a previous coarctation repair. There were 51 patients over 12 years.

No abstract